Therapeutic Proteins : Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2012.
|
| Edición: | 2nd ed. 2012. |
| Colección: | Methods in Molecular Biology,
899 |
| Materias: |
Tabla de Contenidos:
- Therapeutic Proteins
- Synthetic Antibody Libraries
- The Construction of ‘Phylomer’ Peptide Libraries as a Rich Source of Potent Inhibitors of Protein/Protein Interactions
- Ribosome Display and Screening for Protein Therapeutics
- Yeast Display of Engineered Antibody Domains
- Design, Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains
- Engineering of Affibody Molecules for Therapy and Diagnostics
- Protein Design for Diversity of Sequences and Conformations Using Dead-End Elimination
- Design and Generation of DVD-IgTM Molecules for Dual-Specific Targeting
- Engineering and Expression of Bibody and Tribody Constructs in Mammalian Cells and in the Yeast Pichia pastoris
- Use of E. coli for the Production of a Single Protein
- Folding Engineering Strategies for Efficient Membrane Protein Production in E. coli
- Transient Expression Technologies: Past, Present, and Future
- Stable Transfection Pools for Large Quantity of Protein Production
- Mammalian Stable Expression of Biotherapeutics
- Transgenic Expression of Therapeutic Proteins in Arabidopsis thaliana Seed
- Methods for Chromatographic Removal of Endotoxin
- Effectiveness of Various Processing Steps for Viral Clearance of Therapeutic Proteins: Database Analyses of Commonly-Used Steps
- High-Throughput Quantitative N-Glycan Analysis of Glycoproteins
- High-Throughput Multimodal Strong Anion Exchange Purification and N-Glycan Characterization of Endogenous Glycoprotein Expressed in Glycoengineered Pichia pastoris
- Databases and Tools in Glycobiology
- Characterization of PEGylated Biopharmaceutical Products by LC/MS and LC/MS/MS
- Identification of Asp Isomerization in Proteins by 18O Labeling and Tandem Mass Spectrometry
- Monitoring of Subvisible Particles in Therapeutic Proteins
- Size-Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS) for Elucidating Protein Aggregation Mechanisms
- Computational Methods to Predict Therapeutic Protein Aggregation
- Coarse-Grained Simulations of Protein Aggregation
- Chitosan-Based Nanoparticles as Delivery Systems of Therapeutic Proteins
- Challenges in the Development and Manufacturing of Antibody-Drug Conjugates.